Schedule 13G ownership disclosure
Monopar Therapeutics Inc
Security class unavailable · CUSIP: 61023L207
Event date: 2024-10-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 387,329
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-111584
- Form type
- SC 13G
- Filer
- ASTRAZENECA PLC
- CIK
- CIK 901832
- Filed
- Oct 28, 2024
- Reporting period
- Oct 23, 2024
- Description
- Schedule 13G beneficial ownership